Table 2 SSc-ILD, radiologic and histopathologic features and correlations
Ref. | LBx cases/TOTAL SSc-ILD cases (%) | Lung biopsyNSIP | Lung biopsy: cellular NSIP | Lung biopsy: fibrosing-NSIP | Lung biopsy: UIP | Lung biopsy. Other | N of cases with HRCT data | HRCT: NSIP/UIP/other | HRCT concordant with histopathology NSIP/UIP | HRCT discordant (HRCT -> histopathology) |
|---|---|---|---|---|---|---|---|---|---|---|
Fischer, Chest 2008 | 22/27 (82%) | 14/22 (64%) | 1/22(4%) | 13/22(60%) | 8/22(36%) | - | 9 | 8/1/0 | 5/1 | 3 NSIP -> UIP |
Kim, Sarcoidosis VDLD 2002 | 19/19 (100%) | 13/19 (68%) | 2/19 (10%)1 | 11/19 (58%) | 5/19(26%) | 1 end stage lung (hcc only) | 18 | 15/3/0 | 13/3 | 2 NSIP -> UIP |
De Souza, Respiration 2009 | 28/28 (100%) | 19/28 (68%)2 | - | - | 1/28 (3%) | 6 CLF; 1 PH; 1 RB-ILD | 19 | 183/1/0 | 183/0 | 1 UIP -> NSIP4 |
Bouros, AJRCCM 2022 | 80/80 (100%) | 62/80 (77.5%) | 15/80 (19%) | 47/80 (59%) | 6/80 (7.5%) | 6 ESL; 4 RB-ILD, 1 sarcoidosis, 1 OP | - | - | - | - |
de Carvalho, Histopathology 2008 | 18/18 (100%) | 18/18 (100%) | - | 18/18 (100%) | - | - | - | - | - | - |
Felicio, Lung 2007 | 10/10 (100%) | 10/10 (100%) | - | 10/10 (100%) | - | - | - | - | - | - |
Christmann, Arthritis and Rheum 2014 | 21/21 (100%) | 16/21 (76%) | - | - | - | 5 CLF | - | - | - | - |
Domiciano, Clin Rheum 2011 | 24/24 (100%) | 18/24 (75%) | 14/24 (58%) | 4/24 (16%) | Â | 4 CLF; 1 PH; 1 RB-ILD | - | - | - | - |
Yamakawa, PLoS One 2016 | 32/72 (44%) | 20/32 (62%) | - | 20/32 (62%) | 1/32 (3%) | 11 unclassifiable | 72 | 48/10/145 | - | - |
Parra, Brazilian J Med and Biol Res 2013 | 23/23 (100%) | 23/23 (100%) | 11/23 (48%) | 12/23 (52%) | - | - | - | - | - | - |
Harrison, AJRCCM 1991 | 34/34 (100%) | - | - | - | - | 34/346 | - | - | - | - |
Franco De Carvalho, Respiration 2008 | 18/18 (100%) | 18/18 (100%) | - | - | - | - | - | - | - | - |
Xiao, Rheum Dis 2018 | 25/25 (100%) | - | - | - | - | - | - | - | - | - |